RecruitingNCT06081517

Evaluating Disparities in Precision Oncology

Evaluating Disparities in Precision Oncology: An Observational Trial in the Context of a Real-World Academic Practice Model


Sponsor

Indiana University

Enrollment

10,600 participants

Start Date

Jan 26, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Social Determinants of Health and toxicity questionnaires for people with advanced cancer and metastatic cancer. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSocial Determinants of Health and toxicity questionnaires

Collect detailed clinical, and social data from patients to identify significant contributors of disparate survival and toxicity outcomes.


Locations(1)

Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06081517


Related Trials